Readers like you keep news free for everyone.
More than 5,000 readers have already pitched in to keep free access to The Journal.
For the price of one cup of coffee each week you can help keep paywalls away.
Simon Dawson
A blood sample as part of a testing program.
antibody testing
HSE releases results of first Covid-19 antibody study
The HPSC estimates a national prevalence rate of 1.7%.
A HSE STUDY on Covid-19 antibodies in the Irish population has found that 1.7% had antibodies.
The results mean that the Health Protection Surveillance Centre (HPSC) is estimating that 59,500 people in Ireland between the ages of 12 to 69 years had Covid-19 up to mid-July, three times the number of detected cases.
The national prevalence rate of 1.7% is “relatively low” compared to several other European countries, with the HSE saying that these countries have experienced a “much more intense epidemic”.
The study was based on random testing of 1,733 people aged 12 to 69 years in Sligo and Dublin for Covid-19 antibodies.
Of those tested, 33 tested positive for antibodies, 28 in Dublin and five in Sligo. This means a prevalence of infection of 0.6% in Sligo and 3.1% in Dublin.
Based on these results, HPSC estimates a national prevalence rate of 1.7%.
Of those who were found to have antibodies, 73% had symptoms that are included in the Irish Covid-19 case definition. The HSE said there were no statistical differences identified in the prevalence by age group, or between males and females.
“It is not surprising that a relatively low national seroprevalence of 1.7% was observed here,” Dr Derval Igoe of the HPSC said.
Other countries in Europe, such as Spain and Italy, where there has been a much more intense epidemic, have reported national seroprevalence estimates of 5% and 2.5% respectively.
“This means that the vast majority of people living in Ireland had not been infected with SARS-CoV-2 virus by the time of the study.
“As a society, we need to continue with our public health measures, including physical distancing, respiratory etiquette, hand hygiene and the use of face coverings, until a vaccine for Covid-19 is available,” Igoe added.
